Financial Summary (All financials)
| In millions, except per share items | Dec-31-13 | Dec-31-12 | Jan-14-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 |
| Revenues | 0.0 | 0.0 | 144.0 | 1,123.0 | 951.0 | 825.0 |
| Revenue growth | | -100.0% | -84.9% | | 15.3% | |
| Cost of goods sold | 20.1 | 14.3 | 111.0 | 906.0 | 757.0 | 651.0 |
| Gross profit | -20.1 | -14.3 | 33.0 | 217.0 | 194.0 | 174.0 |
| Gross margin | | | 22.9% | 19.3% | 20.4% | 21.1% |
| Selling, general and administrative | 0.0 | 0.0 | 66.0 | 49.0 | 52.0 | 48.0 |
| Research and development | | | 1.0 | 12.0 | 13.0 | 12.0 |
| EBIT | 3.0 | 0.0 | -35.0 | 138.0 | 127.0 | 101.0 |
| EBIT margin | | | -24.3% | 12.3% | 13.4% | 12.2% |
| Pre-tax income | 0.0 | 0.0 | -45.0 | 64.0 | 55.0 | 0.0 |
| Income taxes | 0.0 | 0.0 | 9.0 | 32.0 | 33.0 | 16.0 |
| Tax rate | | | | 50.0% | 60.0% | |
| Net income | 0.0 | 0.0 | -54.0 | 30.0 | 22.0 | 0.0 |
| Net margin | | | -37.5% | 2.7% | 2.3% | 0.0% |
| |
| Diluted EPS | | $0.00 | ($0.05) | $0.03 | $0.02 | $0.00 |
| Shares outstanding (diluted) | | 49.0 | 1,000.0 | 1,000.0 | 1,000.0 | 1,000,000,000.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|